Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
192

Summary

Conditions
  • Obesity
  • Overweight
Type
Interventional
Phase
Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Masking Description: Sponsor staff involved in the clinical trial is masked according to company standard proceduresPrimary Purpose: Treatment

Participation Requirements

Age
Between 12 years and 17 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04102189
Collaborators
Not Provided
Investigators
Study Director: Clinical Reporting Anchor and Disclosure (1452) Novo Nordisk A/S